Shionogi & Co., Ltd. (hereafter “Shionogi”) announced it will present four posters on Mulpleta® (lusutrombopag), a once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist, at The Liver Meeting®, the premiere annual meeting in the science and practice of hepatology from the American Association for the Study of Liver Diseases (AASLD) to be held in San Francisco, November 9-13, 2018.
November 7, 2018
· 7 min read